Amersham Pharmacia Biotech Fulfills Merger Potential.(Company Financial Information)

Chemical Market Reporter, May, 1999 by MIRASOL, FELIZA

IN ITS FIRST FULL YEAR of operation, Amersham Pharmacia Biotech (AP Biotech), the joint venture created by the August 1997 merger of the life science businesses of Nycomed Amersham PLC and Pharmacia & Upjohn Inc. (P&U), enjoyed robust growth while achieving cost synergies and meeting its financial and strategic goals.

Nycomed Amersham owns 55 percent of the joint venture and P&U owns 45 percent. Headquartered in Uppsala, Sweden, AP Biotech is a medical biotechnology company that provides innovative systems for medical research, drug development and the production of biopharmaceuticals. The company combines the engineering and software heritage of P&U and the chemistry and biochemistry knowledge of Nycomed Amersham, enabling it to develop complete systems...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement